FDA issued a Warning Letter to Pharmacy Creations on 6/23/2014 for a previous inspection.
483 ImprimisRx NJ Jul 2017

483 ImprimisRx NJ Jul 2017

Jose Cayuela FDA$119.00 - Available Now

FDA investigators audited the ImprimisRx NJ - Ledgewood, NJ, United States facility and issued inspectional observations (via FDA 483) on 10 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Jul 2017
  • Location: Ledgewood, United States
  • FEI: 3003348498
Add To Cart